Grace Therapeutics (GRCE) Receivables - Net (2017 - 2024)
Grace Therapeutics (GRCE) posted Receivables - Net of $398,000 for fiscal Q1 2025 (quarter ended Jun 30, 2024), down 52.4% from $837,000 a year earlier and down 44.9% from the prior quarter.
Powered by 
Analysis
Grace Therapeutics (GRCE) Receivables - Net (2017 - 2024) Analysis & Trends
At the end of FY2024 (ended Mar 31, 2024), Grace Therapeutics' Receivables - Net came in at $722,000, down 10.0% from FY2023.
- Annual Receivables - Net shows a five-year compound annual growth rate of -9.5% (FY2019 to FY2024).
- In prior fiscal years, Grace Therapeutics' Receivables - Net was $802,000 in FY2023 (+46.4%), $548,000 in FY2022 (+3.4%), $530,000 in FY2021 (-2.9%) and $546,000 in FY2020 (-54.1%).
- The fiscal Q1 2025 figure stands as the lowest quarterly Receivables - Net since fiscal Q3 2022.
- On a year-over-year basis, Receivables - Net increased in four of the last eight quarters, with growth averaging 28.0%.
- The strongest year-over-year quarter for Receivables - Net in the past five years was fiscal Q3 2023, with growth of 226.9%; the weakest was fiscal Q3 2022, with a decline of 61.6%.
- According to Business Quant data, Receivables - Net for the three prior fiscal quarters was $722,000 (Q4 2024), $959,000 (Q3 2024) and $837,000 (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.92 Bn | 1,105.50 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.57 Bn | 536.10 Bn | 17.26 Bn |
| 3 | AbbVie | 501.37 Bn | 474.48 Bn | 12.70 Bn |
| 4 | Merck | 367.96 Bn | 322.33 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.98 Bn | 261.97 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.45 Bn | 235.14 Bn | 12.86 Bn |
| 7 | Amgen | 236.30 Bn | 191.70 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.27 Bn | 164.46 Bn | 6.22 Bn |
| 9 | Pfizer | 169.65 Bn | 116.29 Bn | 10.94 Bn |
| 10 | Grace Therapeutics | 34.51 Mn | -31.76 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 398,000.00 |
| Mar 31, 2024 | 722,000.00 |
| Dec 31, 2023 | 959,000.00 |
| Sep 30, 2023 | 837,000.00 |
| Jun 30, 2023 | 837,000.00 |
| Mar 31, 2023 | 802,000.00 |
| Dec 31, 2022 | 778,000.00 |
| Sep 30, 2022 | 859,000.00 |
| Jun 30, 2022 | 964,000.00 |
| Mar 31, 2022 | 548,000.00 |
| Dec 31, 2021 | 238,000.00 |
| Sep 30, 2021 | 813,000.00 |
| Jun 30, 2021 | 448,000.00 |
| Mar 31, 2021 | 530,000.00 |
| Dec 31, 2020 | 619,000.00 |
| Sep 30, 2020 | 625,000.00 |
| Jun 30, 2020 | 495,000.00 |
| Mar 31, 2020 | 546,000.00 |
| Mar 31, 2019 | 1.18 Mn |
| Mar 31, 2018 | 588,965.65 |
API Access
Grace Therapeutics Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=GRCE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();